SIN3A and pulmonary arterial hypertension: Our findings collectively demonstrated that restoring SIN3a levels in the pulmonary vasculature reversed PAH by limiting adverse hemodynamic profiles and RV remodeling, characterized by attenuated RVSP, PAP, and the Fulton index in the MCT-induced PAH and SuHx-induced PAH model [105].